PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Patient organisations need to tackle transparency
What’s next for AAV gene therapies in 2024?
Beyond approval: Patients pursue alternate paths to get rare disease treatments
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
FDA approves Madrigal’s Rezdiffra as the first NASH therapy
FDA approves BeiGene’s TEVIMBRA for oesophageal cancer
AstraZeneca snaps up Amolyt for $1.05bn to boost rare disease pipeline
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Anocca signs licensing deal for EmendoBio’s gene-editing tech
Q&A: Increasing awareness around digital therapeutics key to realising full potential
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Merck reports drop in net income for fiscal 2023
Moderna reports net loss of $4.7bn for full year 2023
Q4 2023 update: immuno-oncology related M&A activity in the pharmaceutical industry
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Quality versus quantity in T-cell production: Why it doesn’t have to be a trade-off
Automation, risk management, and the manufacture of medical devices
A review of changing regulatory and analytical requirements of free amino acid monographs of the European Pharmacopoeia
Events
Reports
Premium Insights
Newsletters
PT
In person events
Virtual events
.
Other media partners events